We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Diatron MI Plc

Develops, manufactures and markets hematology analyzers, clinical chemistry analyzers, and associated reagents for hu... read more Featured Products: More products

Download Mobile App





Intelligent Walkaway Clinical Chemistry Analyzer Showcased at AACC

By LabMedica International staff writers
Posted on 27 Jul 2015
A global provider of hematology and clinical chemistry analyzers will display its new economic walkaway clinical chemistry analyzer at the 2015 annual meeting of the American Association of Clinical Chemistry (AACC; Washington DC, USA) in Atlanta (GA, USA) during July 28–30, 2015, in booth 2100.

The Pictus P500 by the the Diatron Group (Budapest, Hungary) is a new medium throughput system capable of 215 tests per hour on a typical sample mix is ergonomically designed and user-friendly with a high level of automation that delivers quality results. More...
Its advanced, windows-based software and smart architecture means the P500 is able to offer many features on an accessible platform. These include uninterrupted workflow, enhanced walk-away operation and remote access diagnostics, all of which have only been available on more expensive clinical chemistry systems until now.

The P500 is also user-friendly with well-structured, easy-to-service design and “one window” software featuring an easy-to-use icon interface menu and inventory management. The minimal usage of consumables and low water consumption translate to cost-effectiveness, and the P500’s proven, high quality components ensure the quality results. There is also an optional ISE module available which significantly increases the throughput to over 450 tests/hour.

Related Links:

Diatron
AACC



Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Prefilled Tubes
Prefilled 5.0ml Tubes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.